Assignee profile:

Spectrum Pharmaceuticals, Inc.

City:

Irvine, California

Country:

United States

Published Applications:

50

Last publication date:

2023-10-19

Patent Grants:

35

Last grant date:

2025-07-08

Top Inventors for applications by Spectrum Pharmaceuticals, Inc.

These are the the leading inventors for applications assigned to Spectrum Pharmaceuticals, Inc.:

Recent patent applications by Spectrum Pharmaceuticals, Inc.

Spectrum Pharmaceuticals, Inc. based in Irvine, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2023-10-19 ✅ Patent 12,350,315 granted on 2025-07-08
US20230330184A1
Human necessities

METHODS OF TREATING NEUTORPENIA USING G-CSF PROTEIN COMPLEX

#2 | 2023-08-31 ✅ Patent 12,318,430 granted on 2025-06-03
US20230270822A1
Human necessities

Methods of treating neutorpenia using G-CSF protein complex

#3 | 2023-04-06
US20230106731A1
Human necessities

INHIBITORS OF MUTANT FAMILY TYROSINE-KINASES

#4 | 2023-01-26
US20230027238A1
Human necessities

METHODS OF TREATMENT USING G-CSF PROTEIN COMPLEX

#5 | 2022-09-22
US20220296598A1
Human necessities

Poziotinib Combination with VEGFR2 Inhibitors and Methods of Use Thereof

#6 | 2022-05-19 ✅ Patent 12,202,871 granted on 2025-01-21
US20220153799A1
Chemistry; metallurgy

Methods of treatment using G-CSF protein complex

#7 | 2022-02-24 ✅ Patent 11,883,402 granted on 2024-01-30
US20220056011A1
Chemistry; metallurgy

Crystalline forms of a quinazoline compound and its hydrochloride salts

#8 | 2022-01-20 ✅ Patent 12,171,804 granted on 2024-12-24
US20220016212A1
Human necessities

Methods of treating chemotherapy induced neutropenia using fixed doses of eflapegrastim

#9 | 2021-01-14 ✅ Patent 11,684,655 granted on 2023-06-27
US20210008166A1
Human necessities

Methods of treating neutorpenia using G-CSF protein complex

#10 | 2020-12-03 ✅ Patent 11,267,858 granted on 2022-03-08
US20200377567A1
Chemistry; metallurgy

Methods of treatment using G-CSF protein complex

#11 | 2016-01-14 ✅ Patent 9,511,091 granted on 2016-12-06
US20160008396A1
Human necessities

Rare earth metal compounds, methods of making, and methods of using the same

#12 | 2014-09-25
US20140288143A1
Human necessities

BLADDER CANCER TREATMENT AND METHODS

#13 | 2014-06-12 ✅ Patent 10,350,240 granted on 2019-07-16
US20140161885A1
Human necessities

Lanthanum carbonate hydroxide, lanthanum oxycarbonate and methods of their manufacture and use

#14 | 2014-06-12 ✅ Patent 8,852,543 granted on 2014-10-07
US20140161702A1
Chemistry; metallurgy

Rare earth metal compounds, methods of making, and methods of using the same

#15 | 2014-04-17 ✅ Patent 9,000,031 granted on 2015-04-07
US20140106003A1
Human necessities

Thioxanthone-based autophagy inhibitor therapies to treat cancer

#16 | 2014-03-13 ✅ Patent 9,295,666 granted on 2016-03-29
US20140073680A1
Human necessities

Bladder cancer treatment and methods

#17 | 2013-12-19 ✅ Patent 9,308,235 granted on 2016-04-12
US20130338079A1
Human necessities

Treatment of primary and metastatic carcinoma

#18 | 2013-08-29 ✅ Patent 8,734,818 granted on 2014-05-27
US20130225648A1
Chemistry; metallurgy

Methods for treating cognitive/attention deficit disorders using tetrahydroindolone analogues and derivatives

#19 | 2013-06-13 ✅ Patent 8,957,014 granted on 2015-02-17
US20130150649A1
Human necessities

Sensitization of tumor cells to radiation therapy through administration of endothelin agonists

#20 | 2013-04-25 ✅ Patent 8,729,023 granted on 2014-05-20
US20130102543A1
Human necessities

Methods, compositions and articles of manufacture for contributing to the treatment of cancers

#21 | 2013-04-25 ✅ Patent 8,642,026 granted on 2014-02-04
US20130101552A1
Human necessities

Methods and compositions for contributing to the treatment of cancers

#22 | 2012-10-04 ✅ Patent 8,648,108 granted on 2014-02-11
US20120252861A1
Human necessities

Medical compositions for intravesical treatment of bladder cancer

#23 | 2012-03-22 ✅ Patent 8,377,456 granted on 2013-02-19
US20120070385A1
Chemistry; metallurgy

Methods for treating cognitive/attention deficit disorders using tetrahydroindolone analogues and derivatives

#24 | 2011-12-29
US20110318410A1
Chemistry; metallurgy

RARE EARTH METAL COMPOUNDS, METHODS OF MAKING, AND METHODS OF USING THE SAME

#25 | 2011-12-29 ✅ Patent 8,440,620 granted on 2013-05-14
US20110315575A1
Human necessities

Methods, compositions and articles of manufacture for contributing to the treatment of cancers

#26 | 2011-12-22 ✅ Patent 8,349,802 granted on 2013-01-08
US20110311481A1
Human necessities

Methods and compositions for contributing to the treatment of cancers

#27 | 2011-11-24 ✅ Patent 8,563,592 granted on 2013-10-22
US20110288143A1
Human necessities

Bladder cancer treatment and methods

#28 | 2011-11-17 ✅ Patent 8,961,917 granted on 2015-02-24
US20110280956A1
Human necessities

Lanthanum carbonate hydroxide, lanthanum oxycarbonate and methods of their manufacture and use

#29 | 2011-11-10 ✅ Patent 8,524,762 granted on 2013-09-03
US20110275696A1
Human necessities

Thioxanthone-based autophagy inhibitor therapies to treat cancer

#30 | 2011-10-13
US20110251143A1
Human necessities

STABLE ELSAMITRUCIN SALT FORMULATIONS

#31 | 2011-05-26
US20110123628A1
Chemistry; metallurgy

RARE EARTH METAL COMPOUNDS, METHODS OF MAKING, AND METHODS OF USING THE SAME

#32 | 2010-11-04
US20100278910A1
Chemistry; metallurgy

RARE EARTH METAL COMPOUNDS, METHODS OF MAKING, AND METHODS OF USING THE SAME

#33 | 2010-08-05 ✅ Patent 8,715,603 granted on 2014-05-06
US20100196485A1
Human necessities

Rare earth metal compounds, methods of making, and methods of using the same

#34 | 2010-05-13
US20100119602A1
Human necessities

PHOSPHATE BINDER WITH REDUCED PILL BURDEN

#35 | 2009-09-17 ✅ Patent 8,815,953 granted on 2014-08-26
US20090234022A1
Human necessities

Formulations of vitamin K analogs for topical use

#36 | 2009-09-03 ✅ Patent 8,273,716 granted on 2012-09-25
US20090221569A1
Human necessities

Use of LHRH antagonists for intermittent treatments

#37 | 2009-07-30 ✅ Patent 8,063,233 granted on 2011-11-22
US20090192319A1
Chemistry; metallurgy

Methods for treating cognitive/attention deficit disorders using tetrahydroindolone analogues and derivatives

#38 | 2009-06-18 ✅ Patent 8,030,278 granted on 2011-10-04
US20090155206A1
Human necessities

Methods, compositions and articles of manufacture for contributing to the treatment of cancers

#39 | 2009-03-19
US20090076123A1
Human necessities

Medical Compositions for Intravesical Treatment of Bladder Cancer

#40 | 2008-12-25 ✅ Patent 8,394,757 granted on 2013-03-12
US20080318846A1
Human necessities

Sensitization of tumor cells to radiation therapy through the administration of endothelin agonists

#41 | 2008-10-16 ✅ Patent 8,026,216 granted on 2011-09-27
US20080253994A1
Human necessities

Methods and compositions for contributing to the treatment of cancers

#42 | 2008-07-10 ✅ Patent 7,977,369 granted on 2011-07-12
US20080166402A1
Human necessities

Medical compositions for intravesical treatment of bladder cancer

#43 | 2007-12-20
US20070293445A1
Chemistry; metallurgy

Stable Elsamitrucin Salts Suitable for Pharmaceutical Formulations

#44 | 2007-02-08
US20070032422A1
Human necessities

METHODS, COMPOSITIONS AND ARTICLES OF MANUFACTURE FOR CONTRIBUTING TO THE TREATMENT OF CANCERS

#45 | 2007-01-11
US20070010570A1
Human necessities

Medical Compositions for Intravesical Treatment of Bladder Cancer

#46 | 2006-09-21 ✅ Patent 8,217,010 granted on 2012-07-10
US20060211617A1
Human necessities

Methods, compositions and articles of manufacture for contributing to the treatment of solid tumors

#47 | 2006-03-23
US20060063788A1
Human necessities

Carbon monoxide dependent guanylyl cyclase modifiers and methods of use

#48 | 2006-01-03 ✅ Patent 6,982,269 granted on 2006-01-03
US10193550
-

Methods for treating cognitive/attention deficit disorders using tetrahydroindolone analogues and derivatives

#49 | 2005-09-29
US20050215615A1
Human necessities

Medical compositions for intravesical treatment of bladder cancer

#50 | 2005-05-17 ✅ Patent 6,894,071 granted on 2005-05-17
US10285783
-

Medical compositions for intravesical treatment of bladder cancer

Also check out Spectrum Pharmaceuticals, Inc.'s (Irvine, United States) applicant profile with 16 patent applications submitted.

AssigneeID:

19467 ⎘